Basic Information
| LncRNA/CircRNA Name | circ_0081001 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | doxorubicin | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | qRT-PCR |
| Sample | primary osteosarcoma tissues, osteosarcoma cell lines (MG63,KHOS,U2OS), doxorubicinresistant osteosarcoma cell lines (MG63/DXR, KHOS/DXR, U2OS/DXR) |
| Expression Pattern | up-regulated |
| Function Description | hsa_circ_0081001 was significantly up-regulated in the OS cell lines, tissues and serums. |
| Pubmed ID | 30263004 |
| Year | 2018 |
| Title | A novel circulating hsa_circ_0081001 act as a potential biomarker for diagnosis and prognosis of osteosarcoma |
External Links
| Links for circ_0081001 | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |